Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial.
Agricola JoachimAsli BauerSarah JosephChristof GeldmacherPatricia J MunseriSaid AboudMarco MissangaPhilipp MannBritta WahrenGuido FerrariVictoria R PolonisMerlin L RobbJonathan WeberRoger TatoudLeonard MabokoMichael HoelscherEligius F LyamuyaGunnel BiberfeldEric SandströmArne KroidlMuhammad BakariCharlotta NilssonSheena McCormackPublished in: PloS one (2016)
International Clinical Trials Registry PACTR2010050002122368.
Keyphrases
- antiretroviral therapy
- clinical trial
- hiv positive
- hiv infected
- hiv testing
- human immunodeficiency virus
- immune response
- hepatitis c virus
- hiv aids
- men who have sex with men
- phase ii
- early stage
- phase iii
- study protocol
- south africa
- circulating tumor
- randomized controlled trial
- lymph node metastasis
- open label
- protein protein
- small molecule
- double blind